1. Detection of Minimally Visible Recurrent Retinoblastoma by Hand-held Spectral-Domain Optical Coherence Tomography
- Author
-
Maria E Gonzalez-Montpetit, George N. Magrath, Wasim A. Samara, and Carol L. Shields
- Subjects
Male ,medicine.medical_specialty ,genetic structures ,Retinal Neoplasms ,Spectral domain ,Recurrent retinoblastoma ,Retina ,03 medical and health sciences ,0302 clinical medicine ,Optics ,Optical coherence tomography ,Adjuvant therapy ,medicine ,Humans ,Strabismus ,Subclinical infection ,medicine.diagnostic_test ,business.industry ,Hand held ,Retinoblastoma ,Infant ,Equipment Design ,General Medicine ,eye diseases ,Ophthalmology ,medicine.anatomical_structure ,Fundus (uterus) ,Pediatrics, Perinatology and Child Health ,030221 ophthalmology & optometry ,Female ,sense organs ,Radiology ,Neoplasm Recurrence, Local ,business ,Tomography, Optical Coherence ,030217 neurology & neurosurgery - Abstract
A 2-month-old male infant with bilateral familial retinoblastoma was treated with intravenous chemotherapy and focal adjuvant therapy. At 5 months of follow-up, fundus examination and ultrasonography disclosed no recurrence; however, hand-held spectral-domain optical coherence tomography (SD-OCT) demonstrated subclinical recurrence within a previous regression scar. Subsequent treatment led to flat scar. Hand-held SD-OCT can be a useful tool for detection of subclinical recurrent retinoblastoma. [ J Pediatr Ophthalmol Strabismus . 2017;54:e6–e8.]
- Published
- 2017
- Full Text
- View/download PDF